Bottom line
Is PINK a good fund? The bottom line
PINK is a managed health care sector ETF from Simplify Exchange Traded.
It charges 0.51% — about $51 a year on every $10,000 invested, cheaper than 80% of health care sector funds we track.
It returned +24.1% over one year (as of Dec 31, 2025, per its prospectus).
With $359 million in net assets and 54 holdings, its largest position is Purecycle Technologies Inc (6.9%) and the top 10 make up 56.5% of the portfolio.
What stands out
- Low cost: cheaper than 80% of health care sector peers
What to watch
- Concentrated: top 10 holdings are 56.5% of assets
- High turnover (171% a year) can mean more taxable distributions
Updated Nov 19, 2026
What PINK invests in
Investment Objective: The Simplify Health Care ETF (the Fund or PINK) seeks long-term capital appreciation.
Principal Investment Strategies: The Fund has adopted a non-fundamental policy that, under normal circumstances, the Fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The Fund defines health care companies as companies included in the Global Industry Classification Standard health care sector. The Fund defines equity securities as common stock, preferred stock, or ETFs that invest in the same. The Fund invests in companies without restriction as to capitalization, including micro-capitalization companies. The Fund will invest in 50 to 100 health care companies. The Fund will use fundamental, bottom-up analysis that seeks to identify high-quality companies and the most compelling investment opportunities. In general, the Fund will follow a growth investment strategy, seeking companies whose earnings are…
From the fund's prospectus (filed Oct 28, 2026).
PINK performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| PINK | +24.1% | — | — |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2025
What PINK costs
On a $10,000 investment, PINK's 0.51% expense ratio costs about $51 a year. The prospectus estimates $641 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.
PINK top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Purecycle Technologies Inc PCT | 6.89% |
| 2 | United Therapeutics Corp UTHR | 6.86% |
| 3 | Novo Nordisk A/s NVO | 6.75% |
| 4 | Eli Lilly & Company LLY | 5.91% |
| 5 | Unitedhealth Group Inc UNH | 5.76% |
| 6 | Warby Parker Inc WRBY | 5.46% |
| 7 | Johnson & Johnson JNJ | 5.45% |
| 8 | Jazz Pharmaceuticals Plc JAZZ | 4.61% |
| 9 | Abbvie Inc ABBV | 4.52% |
| 10 | Biohaven Ltd BHVN | 4.32% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 56.5% of the fund. See all top 25 holdings and asset mix →